4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0000905148-24-002303
EVP, CFO sold 1,070 shares at an average $6.63 ($7,093)
From the SEC's structured data for this filing
Trades in this filing
Hyllengren Eric J · EVP, CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-16 | Sale : show line 1 in the form | −1,041 | $6.63 | $6,901 | 24,785 | D |
| 2024-08-16 | Sale : show line 2 in the form | −29 | $6.63 | $192 | 24,756 | D |
| Open-market sales · 1,070 sh · avg $6.63 · $7,093 | ||||||
Loading xslF345X05/form4.xml…